2013
DOI: 10.1016/j.foodres.2012.12.044
|View full text |Cite
|
Sign up to set email alerts
|

Identification of 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one as a strong antioxidant in glucose–histidine Maillard reaction products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
64
0
2

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 135 publications
(67 citation statements)
references
References 18 publications
1
64
0
2
Order By: Relevance
“…Both CAP and DHC contents (Table 3) were higher at HTST and this also indicated the contribution to the antioxidant activity. Additionally, the DDMP compound identi ed from GCMS was also reported to possess strong antioxidant compound in glucose-histidine Maillard reaction products in a study by Yu et al (2013). These results demonstrated that HTST (e.g., 140 °C and 160 °C) in uenced high antioxidant activity, especially the FRAP analysis.…”
Section: Antioxidant Propertiesmentioning
confidence: 82%
“…Both CAP and DHC contents (Table 3) were higher at HTST and this also indicated the contribution to the antioxidant activity. Additionally, the DDMP compound identi ed from GCMS was also reported to possess strong antioxidant compound in glucose-histidine Maillard reaction products in a study by Yu et al (2013). These results demonstrated that HTST (e.g., 140 °C and 160 °C) in uenced high antioxidant activity, especially the FRAP analysis.…”
Section: Antioxidant Propertiesmentioning
confidence: 82%
“…En este caso, la IC 50 fue de 399,39 ug/mL. (DDMP) identiicado como un poderoso antioxidante (29) . inhibidor de la α-glucosidasa (30) y de la NF-Kappa B, un factor de transcripción redox que puede ser activado en situaciones de hiperglicemia crónica (31) .…”
Section: Resultsunclassified
“…www.ajpp.in 0.06 Butyrolactone cdc2 and cdk2 kinases inhibitor, anti-cancer activity, antimicrobial, antidepressant, Flavoring Agents (Giarman et al, 1963;Nishio et al, 1996;Kitagawa et al, 1994) 1.92 4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl-Mutagen, Antimicrobial, anti-inflammatory and antioxidant capacity (Hiramoto et al, 1997;Kumar et al, 2010;Yu et al, 2013) (Jeong et al, 2010;Silici et al, 2005;Jeong et al, 2011;Fukai et al, 2009) (Ghelardini et al, 2001;Tambe et al, 1996;Sabulala et al, 2006;Yang et al, 2000;Huang et al, 2012;Park et al, 2011;Calleja et al, 2013;Dahham et al, 2015;Kumar et al, 2010) (Fernandes et al, 2007;Legault et al, 2003;Legault et al, 2007) 4,6a,6b,8a,11,11,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a, Figure 6). Figure 6).…”
Section: In Vitromentioning
confidence: 99%